New Research Poster Presentation 3.16
Double-Blind, Placebo-Controlled, 36-Week Maintenance Study of Lamotrigine in Youth With Bipolar I Disorder
Thursday, October 23, 2014 1:00 PM
Robert L. Findling, MD, MBA, The Johns Hopkins University/Kennedy Krieger Institute, Baltimore, MD
Kiki Chang, MD, Stanford University School of Medicine, Stanford, CA
Adelaide S. Robb, MD, Child and Adolescent Psychiatry, Children's National Medical Center, Washington, DC
Vicki Foster, MPH, Neuroscience, GlaxoSmithKline, Raleigh, NC
Joseph Horrigan, Neuren Pharmaceuticals, Durham, NC
Alok Krishen, MS, PCPS - Statistics, GlaxoSmithKline, Raleigh, NC
Art W. Wamil, MD, PhD, Neurology, GlaxoSmithKline Neuroscience and Cardiovascular Units, Durham, NC
Melissa P. DelBello, MD, MS, Psychiatry, University of Cincinnati, Cincinnati, OH
